Generating Recombinant Pseudorabies Virus for Use as a Vaccine Platform

Area of Science:

• Veterinary Virology
• Vaccinology
• Molecular Biology

Background:

• Pseudorabies virus (PRV) possesses unique characteristics, including extensive nonessential replication regions and a wide host range, making it a suitable candidate for vaccine vector development.
• The successful insertion and expression of foreign genes from other viruses within PRV have been demonstrated.
• These genetically modified PRV strains hold potential for inducing robust humoral and cellular immune responses in vaccinated animals.

Purpose of the Study:

• To provide a comprehensive overview of the methodologies employed in the generation of recombinant pseudorabies virus (PRV).
• To highlight the utility of PRV as a versatile vector for vaccine development.
• To discuss the potential of recombinant PRV in eliciting protective immunity.

Main Methods:

• Review of established techniques for genetic manipulation of PRV.
• Analysis of strategies for foreign gene insertion and expression within the PRV genome.
• Discussion of methods for characterizing recombinant PRV and assessing their immunogenicity.

Main Results:

• Demonstration of PRV's capacity to accommodate and express foreign genetic material.
• Evidence of recombinant PRV's ability to stimulate both humoral and cellular immunity.
• Identification of key methods for efficient recombinant PRV construction.

Conclusions:

• Recombinant pseudorabies virus (PRV) represents a highly adaptable and effective platform for vaccine vector applications.
• The described methods facilitate the development of novel vaccines against various pathogens.
• PRV-based vaccines offer a promising strategy for enhancing animal health and disease control.